Updates

Cohort - Eps enhancing deal in Portugal; gain since January 58%

September 2015

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

We made Cohort a New Year NAP in the January issue at 236p. Last month, the shares spiked to an all time high after it confirmed the acquisition of EID, a Lisbon-based defence business, for €19m.In 2014 EID had sales of €14.5m and an operating profit of €1.4m – and growth is underpinned by a strong order book (€35.2m, of which €12m is for delivery this year). The deal is expected to be eps enhancing in the year starting 1 May.EID supplies command, control and communications equipment with three distinct elements to its business: Naval Communications (integrated command, control and communications systems for warships); Tactical Communications (radio equipment, vehicle intercom systems and networ ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Quantum Pharma

Optimal Payments - Skrill trading ahead of expectations

Cohort (February 2018)

Cohort (January 2017)

Cohort - Defence firm posts record profits (August 2016)

Cohort (January 2016)

Cohort - 22% organic revenue growth in FY15 (July 2015)

Cohort (May 2015)

Cohort - Defence business with £147m order book on a tear (March 2015)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X